Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
108.83
-2.14 (-1.93%)
Official Closing Price
Updated: 7:00 PM EST, Jan 16, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
14,852,089
Open
110.71
Bid (Size)
109.09 (100)
Ask (Size)
109.30 (200)
Prev. Close
110.97
Today's Range
108.43 - 110.73
52wk Range
73.31 - 112.90
Shares Outstanding
2,531,374,696
Dividend Yield
3.12%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 “Forever Stocks” to Hold When the Market Won’t Sit Still
↗
January 19, 2026
Via
MarketBeat
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
January 19, 2026
As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its...
Via
Finterra
Topics
Artificial Intelligence
Bankruptcy
Economy
Performance
YTD
+2.2%
+2.2%
1 Month
+3.9%
+3.9%
3 Month
+26.1%
+26.1%
6 Month
+37.2%
+37.2%
1 Year
+13.1%
+13.1%
More News
Read More
3 Profitable Stocks to Consider Right Now
January 18, 2026
Via
StockStory
ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe?
↗
January 16, 2026
Via
Stocktwits
Topics
Intellectual Property
Merck & Co. Inc. (NYSE:MRK) Presents a Compelling Value Investment Case
↗
January 14, 2026
Via
Chartmill
Merck In Talks To Acquire Revolution Medicines For About $30B: Report
↗
January 09, 2026
Via
Stocktwits
Merck Looks To Buy Cancer Drugmaker Revolution Medicines: Report
↗
January 08, 2026
Via
Stocktwits
The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026
January 16, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
Lawsuit
2 Unpopular Stocks That Should Get More Attention and 1 We Brush Off
January 15, 2026
Via
StockStory
The Execution Engine: How Merck is Dominating the 2026 Pharma Landscape
January 15, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
Healthcare Titan Ascendant: Johnson & Johnson Hits All-Time Highs as It Navigates a New Political and Clinical Era
January 15, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Bankruptcy
Earnings
A Whole Watchlist of “Coiled Springs” (Found With One Simple ChartMill Screen)
↗
January 15, 2026
Via
Chartmill
Moderna’s High-Stakes Transformation: Navigating the Post-Pandemic Pivot
January 14, 2026
Via
Finterra
Topics
Initial Public Offering
Intellectual Property
The mRNA Pivot: Moderna Navigates Regulatory Headwinds and Tariff Turmoil in a Volatile 2026 Biotech Landscape
January 12, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
World Trade
Revolution Medicines Dismisses Merck, Abbvie Buyout Talks While Analyst Say It Is Worth More Than $32B
↗
January 12, 2026
Via
Stocktwits
The AI-Bio Convergence: Lilly and Nvidia Kick Off JPM26 with Landmark $1 Billion Alliance
January 12, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
3 Dividend Stocks to Hold for the Next 10 Years
↗
January 12, 2026
Via
The Motley Fool
Topics
Bonds
1 Momentum Stock Worth Your Attention and 2 Facing Headwinds
January 11, 2026
Via
StockStory
This ETF Is Proof That the Healthcare Rebound Is Real
↗
January 11, 2026
Via
MarketBeat
Topics
ETFs
Why Revolution Medicines Stock Surged by 11% Today
↗
January 09, 2026
Via
The Motley Fool
Topics
Intellectual Property
MoonLake Immunotherapeutics Surges as FDA "De-Risks" Sonelokimab, Reigniting Multi-Billion Dollar Takeover Speculation
January 09, 2026
Via
MarketMinute
Topics
Intellectual Property
Moderna’s Second Act: A 2026 Deep Dive into the Future of mRNA Therapeutics
January 09, 2026
Via
PredictStreet
Topics
Initial Public Offering
Intellectual Property
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight
↗
January 09, 2026
Via
Benzinga
J&J Cuts Deal With Trump’s White House To Slash Drug Prices And Dodge Tariffs
↗
January 08, 2026
Via
Stocktwits
Topics
Government
American Trade Resilience: Deficit Hits 17-Year Low as Export Surge and Tariff Shocks Reshape Global Commerce
January 08, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Frequently Asked Questions
Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 108.83
When was Merck & Co last traded?
The last trade of Merck & Co was at 01/16/26 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 275.49B
How many shares of Merck & Co are outstanding?
Merck & Co has 275B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.